Dr. David Perlmutter
speaker
551 appearances
1 recordings
1 series
first heard Jul 2026
last heard 9 Jul
Dr. David Perlmutter’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
I'll let somebody figure that one out.
I didn't say evenly.
That one guy.
You're the half.
And half got a GLP1 agonist drug daily, the other half got a placebo daily, and they follow these people for a year.
They follow them on what's called the unified Parkinson's disease rating scale, UPDRS, and well-accepted scale used in studying uh Parkinson's.
The group that received the placebo, as one would expect over the course of a year, declined.
They were were they needed more medicine, they were less functional.
The group that received the GLP1 drug actually stabilized, or if you look at the data carefully, had a tiny bit of improvement, not enough to say they improved.
But if you look at the graph, it's slightly positive.
But I don't even if it's stabilized, that's a home run.
That's targeting the fire, not the smoke.
In Parkinson's, we have to target the smoke, the symptoms.
We have to use drugs for rigidity and tremor.
I get that.
But to say that I'm using these drugs to treat Parkinson's is wrong.
You're treating the symptoms.
As an example, uh, you're taking a blood pressure pill for what?
To treat your high blood pressure.
Well, you're actually not.
Showing 341–360 of 551 · page 18 of 28
← Previous
Next →